Research Article

GLP-1 Gene-Modified Human Umbilical Cord Mesenchymal Stem Cell Line Improves Blood Glucose Level in Type 2 Diabetic Mice

Figure 4

Evaluation of changes in insulin sensitivity after 3 weeks of injection of cell lines. (a) Serum fasting insulin levels were varied in each dose group at 3 weeks of dosing and 3 weeks of drug withdrawal. (b) HOMA-IR changes in each dose group at 3 weeks of administration and 3 weeks after drug withdrawal. (c) Intravenous insulin (0.75 U/kg) was administered to each dose group at 3 weeks of administration, and blood glucose levels were monitored every 30 minutes for 2 hours. (d) Insulin resistance AUC. Data are (). ap, b, compared with the diabetes control mice; c, d, compared with Ad-GFP-hUC-MSC control mice.
(a)
(b)
(c)
(d)